Sixty-one overweight and obese adults with dyslipidemia and insulin resistance were randomized to placebo , @g/day extended-release nicotinic acid ( ERN ) , @g/day prescription omega-@ fatty acid ethyl ester ( P-OM@ ) , or combination therapy for @ weeks .